Thrivent Financial for Lutherans
ORGO icon

Thrivent Financial for Lutherans’s Organogenesis Holdings ORGO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-72,514
Closed -$195K – 2488
2022
Q4 		$195K Sell
72,514
-548
-0.8% -$1.6K ﹤0.01% 2360
2022
Q3 		$237K Buy
73,062
+10,898
+18% +$49.2K ﹤0.01% 2301
2022
Q2 		$303K Buy
62,164
+10,848
+21% +$66.8K ﹤0.01% 2258
2022
Q1 		$391K Buy
51,316
+18
+0% +$139 ﹤0.01% 2281
2021
Q4 		$474K Buy
51,298
+370
+0.7% +$3.93K ﹤0.01% 2205
2021
Q3 		$725K Buy
50,928
+10,049
+25% +$156K ﹤0.01% 2012
2021
Q2 		$679K Buy
+40,879
New +$762K ﹤0.01% 2068

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Thrivent Financial for Lutherans's ORGO Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 72,514 shares — an estimated $195K sold.

Thrivent Financial for Lutherans first reported a position in ORGO in Q2 2021 and held it in 7 quarters. The position peaked at $725K in Q3 2021. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Thrivent Financial for Lutherans reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 72,514 Organogenesis Holdings shares in Q1 2023, an estimated $195K.
  • Thrivent Financial for Lutherans first reported a position in Organogenesis Holdings in Q2 2021 and held it in 7 quarters.
  • Thrivent Financial for Lutherans's Organogenesis Holdings position peaked at $725K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.